CEO and President Jean-Manassé Theagene, brings with him an impressive 20 years of success in pharmaceutical marketing and digital health.
He founded 360Medlink in 2010, raising it from the ground up into a dedicated team of fifty high level professionals who work to serve a diverse range of clients ranging from pharma, government agencies, and payers. Previous to that, he established Pharmxpand, a pioneer start-up that launched the first liver disease non-invasive diagnostic test.
Manassé holds an MSc in Criminology along with an MBA. In his very first international marketing role he chose to work on Subutex/Suboxone, today’s leading treatment for opioid addiction and pursued global oncology marketing at Novartis and in CNS/CV at Schering-Plough.
He is passionate about healthcare, technology, culture and empowering vulnerable populations to improve their quality of life.
At FWD50, we know that experimentation is key to growth and innovation. At last year’s conference, attendees told us they wanted a chance to network and discuss hot topics and specific domains. So in partnership with BlackBerry we created an entirely new, participant-driven format called Circlesquare.
We surveyed people to find the critical technologies and departments. And we chose these...